Skip to content

BZAI BZAI Non-cash financing expense related to issuance of warrants

Non-cash financing expense related to issuance of warrants at other companies

Evommune
 logo
Evommune EVMN
$150
Opus Genetics logo
Opus GeneticsIRD
$0-100%
Evommune
 logo
Evommune EVMN
$150
NovaGold Resources logo
NovaGold ResourcesNG
$0-100%
Opus Genetics logo
Opus GeneticsIRD
$0-100%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$0

Other financials

Income statement

See full
Revenue$2.7M+172%
Gross profit$1.6M+132%
Operating income-$23.4M+38.5%
Net income-$22.7M+84.7%
EPS (diluted)-$0.19+88.2%

Balance sheet

See full
Cash & equivalents$33.5M-26.0%
Total debt$1.2M-22.4%
Total equity$25.4M+52.3%
Total assets$70.8M-29.4%

Cash flow

See full
Operating cash flow-$12.6M+20.8%
CapEx$116.0K-82.5%
Free cash flow-$12.7M+23.2%

Valuation

See full
Market cap$196.37M-29.3%
Enterprise value$164.13M-34.5%
P/S4.9×-68.8×

Profitability

See full
Gross margin17.6%-52.6pp
Operating margin-221%-107pp
Net margin-202.7%-100pp
FCF margin-175.1%-85.1pp

Returns & leverage

See full
Return on equity-388.1%
Debt / equity0.0×
Current ratio2.5×0.0×

Where this comes from

Reported directly by BZAI in its filing.

Tagged under the XBRL concept blz:NoncashFinancingExpenseIssuanceOfWarrants.

The official record: BZAI’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about BZAI's non-cash financing expense related to issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BZAI's non-cash financing expense related to issuance of warrants?
BZAI (BZAI) reported non-cash financing expense related to issuance of warrants of $268.25K in Q4 2025.
What does non-cash financing expense related to issuance of warrants mean?
Reflects the non-cash expense recognized when warrants are issued as part of a financing or service agreement. By adjusting for this, investors can isolate the impact of equity-linked compensation or financing costs from core operating cash flows. This metric highlights the dilution-related costs that do not immediately impact the company's liquidity.